Vigabatrin(CAS?60643-86-9) is a gamma-amino acid having a gamma-vinyl GABA structure.
This report contains market size and forecasts of Vigabatrin API in global, including the following market information:
Global Vigabatrin API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vigabatrin API Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Vigabatrin API companies in 2021 (%)
The global Vigabatrin API market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Above 98 % Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vigabatrin API include Hetero Drugs, Aurobindo Pharma Limited, Intas Pharmaceuticals, Metrochem API Private Limited, SMS Pharmaceuticals, Biophore India Pharmaceuticals Pvt Ltd, Divis Laboratories Ltd., Granules India Limited and Guangzhou Tosun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Vigabatrin API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vigabatrin API Market, by Purity, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Vigabatrin API Market Segment Percentages, by Purity, 2021 (%)
Above 98 %
Above 99 %
Global Vigabatrin API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Vigabatrin API Market Segment Percentages, by Application, 2021 (%)
Tablets
Oral Solution
Others
Global Vigabatrin API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Vigabatrin API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vigabatrin API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vigabatrin API revenues share in global market, 2021 (%)
Key companies Vigabatrin API sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Vigabatrin API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hetero Drugs
Aurobindo Pharma Limited
Intas Pharmaceuticals
Metrochem API Private Limited
SMS Pharmaceuticals
Biophore India Pharmaceuticals Pvt Ltd
Divis Laboratories Ltd.
Granules India Limited
Guangzhou Tosun Pharmaceutical
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Vigabatrin API Market Definition
1.2 Market Segments
1.2.1 Market by Purity
1.2.2 Market by Application
1.3 Global Vigabatrin API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vigabatrin API Overall Market Size
2.1 Global Vigabatrin API Market Size: 2021 VS 2028
2.2 Global Vigabatrin API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Vigabatrin API Sales: 2017-2028
3 Company Landscape
3.1 Top Vigabatrin API Players in Global Market
3.2 Top Global Vigabatrin API Companies Ranked by Revenue
3.3 Global Vigabatrin API Revenue by Companies
3.4 Global Vigabatrin API Sales by Companies
3.5 Global Vigabatrin API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Vigabatrin API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Vigabatrin API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vigabatrin API Players in Global Market
3.8.1 List of Global Tier 1 Vigabatrin API Companies
3.8.2 List of Global Tier 2 and Tier 3 Vigabatrin API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Purity - Global Vigabatrin API Market Size Markets, 2021 & 2028
4.1.2 Above 98 %
4.1.3 Above 99 %
4.2 By Purity - Global Vigabatrin API Revenue & Forecasts
4.2.1 By Purity - Global Vigabatrin API Revenue, 2017-2022
4.2.2 By Purity - Global Vigabatrin API Revenue, 2023-2028
4.2.3 By Purity - Global Vigabatrin API Revenue Market Share, 2017-2028
4.3 By Purity - Global Vigabatrin API Sales & Forecasts
4.3.1 By Purity - Global Vigabatrin API Sales, 2017-2022
4.3.2 By Purity - Global Vigabatrin API Sales, 2023-2028
4.3.3 By Purity - Global Vigabatrin API Sales Market Share, 2017-2028
4.4 By Purity - Global Vigabatrin API Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Vigabatrin API Market Size, 2021 & 2028
5.1.2 Tablets
5.1.3 Oral Solution
5.1.4 Others
5.2 By Application - Global Vigabatrin API Revenue & Forecasts
5.2.1 By Application - Global Vigabatrin API Revenue, 2017-2022
5.2.2 By Application - Global Vigabatrin API Revenue, 2023-2028
5.2.3 By Application - Global Vigabatrin API Revenue Market Share, 2017-2028
5.3 By Application - Global Vigabatrin API Sales & Forecasts
5.3.1 By Application - Global Vigabatrin API Sales, 2017-2022
5.3.2 By Application - Global Vigabatrin API Sales, 2023-2028
5.3.3 By Application - Global Vigabatrin API Sales Market Share, 2017-2028
5.4 By Application - Global Vigabatrin API Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Vigabatrin API Market Size, 2021 & 2028
6.2 By Region - Global Vigabatrin API Revenue & Forecasts
6.2.1 By Region - Global Vigabatrin API Revenue, 2017-2022
6.2.2 By Region - Global Vigabatrin API Revenue, 2023-2028
6.2.3 By Region - Global Vigabatrin API Revenue Market Share, 2017-2028
6.3 By Region - Global Vigabatrin API Sales & Forecasts
6.3.1 By Region - Global Vigabatrin API Sales, 2017-2022
6.3.2 By Region - Global Vigabatrin API Sales, 2023-2028
6.3.3 By Region - Global Vigabatrin API Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Vigabatrin API Revenue, 2017-2028
6.4.2 By Country - North America Vigabatrin API Sales, 2017-2028
6.4.3 US Vigabatrin API Market Size, 2017-2028
6.4.4 Canada Vigabatrin API Market Size, 2017-2028
6.4.5 Mexico Vigabatrin API Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Vigabatrin API Revenue, 2017-2028
6.5.2 By Country - Europe Vigabatrin API Sales, 2017-2028
6.5.3 Germany Vigabatrin API Market Size, 2017-2028
6.5.4 France Vigabatrin API Market Size, 2017-2028
6.5.5 U.K. Vigabatrin API Market Size, 2017-2028
6.5.6 Italy Vigabatrin API Market Size, 2017-2028
6.5.7 Russia Vigabatrin API Market Size, 2017-2028
6.5.8 Nordic Countries Vigabatrin API Market Size, 2017-2028
6.5.9 Benelux Vigabatrin API Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Vigabatrin API Revenue, 2017-2028
6.6.2 By Region - Asia Vigabatrin API Sales, 2017-2028
6.6.3 China Vigabatrin API Market Size, 2017-2028
6.6.4 Japan Vigabatrin API Market Size, 2017-2028
6.6.5 South Korea Vigabatrin API Market Size, 2017-2028
6.6.6 Southeast Asia Vigabatrin API Market Size, 2017-2028
6.6.7 India Vigabatrin API Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Vigabatrin API Revenue, 2017-2028
6.7.2 By Country - South America Vigabatrin API Sales, 2017-2028
6.7.3 Brazil Vigabatrin API Market Size, 2017-2028
6.7.4 Argentina Vigabatrin API Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Vigabatrin API Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Vigabatrin API Sales, 2017-2028
6.8.3 Turkey Vigabatrin API Market Size, 2017-2028
6.8.4 Israel Vigabatrin API Market Size, 2017-2028
6.8.5 Saudi Arabia Vigabatrin API Market Size, 2017-2028
6.8.6 UAE Vigabatrin API Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Hetero Drugs
7.1.1 Hetero Drugs Corporate Summary
7.1.2 Hetero Drugs Business Overview
7.1.3 Hetero Drugs Vigabatrin API Major Product Offerings
7.1.4 Hetero Drugs Vigabatrin API Sales and Revenue in Global (2017-2022)
7.1.5 Hetero Drugs Key News
7.2 Aurobindo Pharma Limited
7.2.1 Aurobindo Pharma Limited Corporate Summary
7.2.2 Aurobindo Pharma Limited Business Overview
7.2.3 Aurobindo Pharma Limited Vigabatrin API Major Product Offerings
7.2.4 Aurobindo Pharma Limited Vigabatrin API Sales and Revenue in Global (2017-2022)
7.2.5 Aurobindo Pharma Limited Key News
7.3 Intas Pharmaceuticals
7.3.1 Intas Pharmaceuticals Corporate Summary
7.3.2 Intas Pharmaceuticals Business Overview
7.3.3 Intas Pharmaceuticals Vigabatrin API Major Product Offerings
7.3.4 Intas Pharmaceuticals Vigabatrin API Sales and Revenue in Global (2017-2022)
7.3.5 Intas Pharmaceuticals Key News
7.4 Metrochem API Private Limited
7.4.1 Metrochem API Private Limited Corporate Summary
7.4.2 Metrochem API Private Limited Business Overview
7.4.3 Metrochem API Private Limited Vigabatrin API Major Product Offerings
7.4.4 Metrochem API Private Limited Vigabatrin API Sales and Revenue in Global (2017-2022)
7.4.5 Metrochem API Private Limited Key News
7.5 SMS Pharmaceuticals
7.5.1 SMS Pharmaceuticals Corporate Summary
7.5.2 SMS Pharmaceuticals Business Overview
7.5.3 SMS Pharmaceuticals Vigabatrin API Major Product Offerings
7.5.4 SMS Pharmaceuticals Vigabatrin API Sales and Revenue in Global (2017-2022)
7.5.5 SMS Pharmaceuticals Key News
7.6 Biophore India Pharmaceuticals Pvt Ltd
7.6.1 Biophore India Pharmaceuticals Pvt Ltd Corporate Summary
7.6.2 Biophore India Pharmaceuticals Pvt Ltd Business Overview
7.6.3 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Major Product Offerings
7.6.4 Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Sales and Revenue in Global (2017-2022)
7.6.5 Biophore India Pharmaceuticals Pvt Ltd Key News
7.7 Divis Laboratories Ltd.
7.7.1 Divis Laboratories Ltd. Corporate Summary
7.7.2 Divis Laboratories Ltd. Business Overview
7.7.3 Divis Laboratories Ltd. Vigabatrin API Major Product Offerings
7.7.4 Divis Laboratories Ltd. Vigabatrin API Sales and Revenue in Global (2017-2022)
7.7.5 Divis Laboratories Ltd. Key News
7.8 Granules India Limited
7.8.1 Granules India Limited Corporate Summary
7.8.2 Granules India Limited Business Overview
7.8.3 Granules India Limited Vigabatrin API Major Product Offerings
7.8.4 Granules India Limited Vigabatrin API Sales and Revenue in Global (2017-2022)
7.8.5 Granules India Limited Key News
7.9 Guangzhou Tosun Pharmaceutical
7.9.1 Guangzhou Tosun Pharmaceutical Corporate Summary
7.9.2 Guangzhou Tosun Pharmaceutical Business Overview
7.9.3 Guangzhou Tosun Pharmaceutical Vigabatrin API Major Product Offerings
7.9.4 Guangzhou Tosun Pharmaceutical Vigabatrin API Sales and Revenue in Global (2017-2022)
7.9.5 Guangzhou Tosun Pharmaceutical Key News
8 Global Vigabatrin API Production Capacity, Analysis
8.1 Global Vigabatrin API Production Capacity, 2017-2028
8.2 Vigabatrin API Production Capacity of Key Manufacturers in Global Market
8.3 Global Vigabatrin API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vigabatrin API Supply Chain Analysis
10.1 Vigabatrin API Industry Value Chain
10.2 Vigabatrin API Upstream Market
10.3 Vigabatrin API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vigabatrin API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Vigabatrin API in Global Market
Table 2. Top Vigabatrin API Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Vigabatrin API Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Vigabatrin API Revenue Share by Companies, 2017-2022
Table 5. Global Vigabatrin API Sales by Companies, (Kg), 2017-2022
Table 6. Global Vigabatrin API Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Vigabatrin API Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Vigabatrin API Product Type
Table 9. List of Global Tier 1 Vigabatrin API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vigabatrin API Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Purity - Global Vigabatrin API Revenue, (US$, Mn), 2021 & 2028
Table 12. By Purity - Global Vigabatrin API Revenue (US$, Mn), 2017-2022
Table 13. By Purity - Global Vigabatrin API Revenue (US$, Mn), 2023-2028
Table 14. By Purity - Global Vigabatrin API Sales (Kg), 2017-2022
Table 15. By Purity - Global Vigabatrin API Sales (Kg), 2023-2028
Table 16. By Application - Global Vigabatrin API Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Vigabatrin API Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Vigabatrin API Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Vigabatrin API Sales (Kg), 2017-2022
Table 20. By Application - Global Vigabatrin API Sales (Kg), 2023-2028
Table 21. By Region - Global Vigabatrin API Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Vigabatrin API Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Vigabatrin API Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Vigabatrin API Sales (Kg), 2017-2022
Table 25. By Region - Global Vigabatrin API Sales (Kg), 2023-2028
Table 26. By Country - North America Vigabatrin API Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Vigabatrin API Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Vigabatrin API Sales, (Kg), 2017-2022
Table 29. By Country - North America Vigabatrin API Sales, (Kg), 2023-2028
Table 30. By Country - Europe Vigabatrin API Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Vigabatrin API Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Vigabatrin API Sales, (Kg), 2017-2022
Table 33. By Country - Europe Vigabatrin API Sales, (Kg), 2023-2028
Table 34. By Region - Asia Vigabatrin API Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Vigabatrin API Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Vigabatrin API Sales, (Kg), 2017-2022
Table 37. By Region - Asia Vigabatrin API Sales, (Kg), 2023-2028
Table 38. By Country - South America Vigabatrin API Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Vigabatrin API Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Vigabatrin API Sales, (Kg), 2017-2022
Table 41. By Country - South America Vigabatrin API Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Vigabatrin API Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Vigabatrin API Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Vigabatrin API Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Vigabatrin API Sales, (Kg), 2023-2028
Table 46. Hetero Drugs Corporate Summary
Table 47. Hetero Drugs Vigabatrin API Product Offerings
Table 48. Hetero Drugs Vigabatrin API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. Aurobindo Pharma Limited Corporate Summary
Table 50. Aurobindo Pharma Limited Vigabatrin API Product Offerings
Table 51. Aurobindo Pharma Limited Vigabatrin API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Intas Pharmaceuticals Corporate Summary
Table 53. Intas Pharmaceuticals Vigabatrin API Product Offerings
Table 54. Intas Pharmaceuticals Vigabatrin API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Metrochem API Private Limited Corporate Summary
Table 56. Metrochem API Private Limited Vigabatrin API Product Offerings
Table 57. Metrochem API Private Limited Vigabatrin API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. SMS Pharmaceuticals Corporate Summary
Table 59. SMS Pharmaceuticals Vigabatrin API Product Offerings
Table 60. SMS Pharmaceuticals Vigabatrin API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Biophore India Pharmaceuticals Pvt Ltd Corporate Summary
Table 62. Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Product Offerings
Table 63. Biophore India Pharmaceuticals Pvt Ltd Vigabatrin API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Divis Laboratories Ltd. Corporate Summary
Table 65. Divis Laboratories Ltd. Vigabatrin API Product Offerings
Table 66. Divis Laboratories Ltd. Vigabatrin API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Granules India Limited Corporate Summary
Table 68. Granules India Limited Vigabatrin API Product Offerings
Table 69. Granules India Limited Vigabatrin API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Guangzhou Tosun Pharmaceutical Corporate Summary
Table 71. Guangzhou Tosun Pharmaceutical Vigabatrin API Product Offerings
Table 72. Guangzhou Tosun Pharmaceutical Vigabatrin API Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Vigabatrin API Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 74. Global Vigabatrin API Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Vigabatrin API Production by Region, 2017-2022 (Kg)
Table 76. Global Vigabatrin API Production by Region, 2023-2028 (Kg)
Table 77. Vigabatrin API Market Opportunities & Trends in Global Market
Table 78. Vigabatrin API Market Drivers in Global Market
Table 79. Vigabatrin API Market Restraints in Global Market
Table 80. Vigabatrin API Raw Materials
Table 81. Vigabatrin API Raw Materials Suppliers in Global Market
Table 82. Typical Vigabatrin API Downstream
Table 83. Vigabatrin API Downstream Clients in Global Market
Table 84. Vigabatrin API Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Vigabatrin API Segment by Purity
Figure 2. Vigabatrin API Segment by Application
Figure 3. Global Vigabatrin API Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vigabatrin API Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vigabatrin API Revenue, 2017-2028 (US$, Mn)
Figure 7. Vigabatrin API Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Vigabatrin API Revenue in 2021
Figure 9. By Purity - Global Vigabatrin API Sales Market Share, 2017-2028
Figure 10. By Purity - Global Vigabatrin API Revenue Market Share, 2017-2028
Figure 11. By Purity - Global Vigabatrin API Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Vigabatrin API Sales Market Share, 2017-2028
Figure 13. By Application - Global Vigabatrin API Revenue Market Share, 2017-2028
Figure 14. By Application - Global Vigabatrin API Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Vigabatrin API Sales Market Share, 2017-2028
Figure 16. By Region - Global Vigabatrin API Revenue Market Share, 2017-2028
Figure 17. By Country - North America Vigabatrin API Revenue Market Share, 2017-2028
Figure 18. By Country - North America Vigabatrin API Sales Market Share, 2017-2028
Figure 19. US Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Vigabatrin API Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Vigabatrin API Sales Market Share, 2017-2028
Figure 24. Germany Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 25. France Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Vigabatrin API Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Vigabatrin API Sales Market Share, 2017-2028
Figure 33. China Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 37. India Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Vigabatrin API Revenue Market Share, 2017-2028
Figure 39. By Country - South America Vigabatrin API Sales Market Share, 2017-2028
Figure 40. Brazil Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Vigabatrin API Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Vigabatrin API Sales Market Share, 2017-2028
Figure 44. Turkey Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Vigabatrin API Revenue, (US$, Mn), 2017-2028
Figure 48. Global Vigabatrin API Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Vigabatrin API by Region, 2021 VS 2028
Figure 50. Vigabatrin API Industry Value Chain
Figure 51. Marketing Channels
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)